MOG and ocular melanoma: Instead, we show here that OM-MOG targets circulating Ly6ChiCCR2+ myeloid progenitor cells, inducing their maturation and thereby trapping them in the periphery, and resulting in prevention or treatment of disease depending upon the stage of OM-MOG administration.